The role of NMDA receptors in the development of brain resistance through pre- and postconditioning

Aging and Disease

Volumn 5, Issue 6, 2014, Pages 430-442

  Constantino, Leandra Celso ^a   Tasca, Carla Inês ^a   Boeck, Carina Rodrigues ^b  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

N methyl D aspartate receptors; Neuroprotection; Postconditioning; Preconditioning

Indexed keywords

EID: 84930661521     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2014.0500430     Document Type: Review

References (129)

1. Rejdak R, Rejdak K, Sieklucka-Dziuba M, Stelmasiak Z, and Grieb P (2001). Brain tolerance and preconditioning. Pol J Pharmacol, 53: 73-79
2. JanoffA (1964). Alterations in Lysosomes (Intracellular Enzymes) during Shock; Effects of Preconditioning (Tolerance) and Protective Drugs. Int Anesthesiol Clin, 2: 251-269
3. Dirnagl U, Simon RP, and Hallenbeck JM (2003). Ischemic tolerance and endogenous neuroprotection. Trends Neurosci, 26: 248-254
4. Mergenthaler P, Dirnagl U, and Meisel A (2004). Pathophysiology of stroke: lessons from animal models. Metab Brain Dis, 19: 151-167
5. Murry CE, Jennings RB, and Reimer KA (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 74: 1124-1136
6. Kitagawa K, Matsumoto M, Kuwabara K, Tagaya M, Ohtsuki T, Hata R, Ueda H, Handa N, Kimura K, and Kamada T (1991). 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res, 561: 203-211
7. Bond A, Lodge D, Hicks CA, Ward MA, and O'Neill MJ (1999). NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus. Eur J Pharmacol, 380, 91-99
8. Schaller B and Graf R (2002). Cerebral ischemic preconditioning. An experimental phenomenon or a clinical important entity of stroke prevention? J Neurol, 249: 1503-1511
9. Samoilov MO, Lazarevich EV, Semenov DG, Mokrushin AA, Tyul'kova EI, Romanovskii DY, Milyakova EA, and Dudkin KN (2003). The adaptive effects of hypoxic preconditioning of brain neurons. Neurosci Behav Physiol, 33: 1-11
10. McIntosh TK (1993). Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review. J Neurotrauma, 10: 215-261
11. Gagliardi RJ (2000). Neuroprotection, excitotoxicity and NMDA antagonists. Arq Neuropsiquiatr, 58, 583-588
12. Meldrum BS (2000). Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr, 130: 1007S-1015S
13. Dempsey RJ, Baskaya MK, and Dogan A (2000). Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats. Neurosurgery, 47: 399-404
14. Jorgensen MB and Diemer NH (1982). Selective neuron loss after cerebral ischemia in the rat: possible role of transmitter glutamate. Acta Neurol Scand 66, 536-546
15. Tymianski M (2011). Emerging mechanisms of disrupted cellular signaling in brain ischemia. Nat Neurosci, 14: 1369-1373
16. Baker AJ, Moulton RJ, MacMillan VH, and Shedden PM (1993). Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. J Neurosurg, 79: 369-372
17. Faden AI, Demediuk P, Panter SS, and Vink R (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science, 244: 798-800
18. Koura SS, Doppenberg EM, Marmarou A, Choi S, Young HF, and Bullock R (1998). Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir Suppl, 71, 244-246
19. Boll MC, Alcaraz-Zubeldia M, and Rios C (2011). Medical management of Parkinson's disease: focus on neuroprotection. Curr Neuropharmacol, 9: 350-359
20. Chen L, Liu J, Ali U, Gui ZH, Hou C, Fan LL, Wang Y, and Wang T (2011). Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions. Brain Res Bull, 84: 215-223
21. Cassano T, Serviddio G, Gaetani S, Romano A, Dipasquale P, Cianci S, Bellanti F, Laconca L, Romano AD, Padalino I, LaFerla FM, Nicoletti F, Cuomo V, and Vendemiale G (2012). Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease. Neurobiol Aging, 33: 1121 e1121-1112
22. Ginsberg SD, Hemby SE, and Smiley JF (2012). Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder. Pharmacol Biochem Behav, 100: 705-711
23. Moghaddam B and Javitt D (2012). From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology, 37:4-15
24. Sanacora G, Zarate CA, Krystal JH, and Manji HK (2008). Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov, 7: 426-437
25. Lau A and Tymianski M (2010). Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch, 460: 525-542
26. Choi DW (1985). Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett, 58: 293-297
27. Stone TW and Addae JI (2002). The pharmacological manipulation of glutamate receptors and neuroprotection. Eur J Pharmacol, 447: 285-296
28. Hynd MR, Scott HL, and Dodd PR (2004). Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int, 45: 583-595
29. Nichols RA, Dengler AF, Nakagawa EM, Bashkin M, Paul BT, Wu J, and Khan GM (2007). A constitutive, transient receptor potential-like Ca2+ influx pathway in presynaptic nerve endings independent of voltage-gated Ca2+ channels and Na+/Ca2+ exchange. J Biol Chem, 282: 36102-36111
30. Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, and Choi AM (2007). Mechanisms of cell death in oxidative stress. Antioxid Redox Signal, 9: 49-89
31. Boeck CR, Carbonera LS, Milioli ME, Constantino LC, Garcez ML, Rezin GT, Scaini G, and Streck EL (2013). Mitochondrial respiratory chain and creatine kinase activities following trauma brain injury in brain of mice preconditioned with N-methyl-D-aspartate. Mol Cell Biochem, in press
32. Gonda X (2012). Basic pharmacology of NMDA receptors. Curr Pharm Des, 18: 1558-1567
33. Hardingham GE (2009). Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans, 37: 1147-1160
34. Cull-Candy S, Brickley S, and Farrant M (2001). NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol, 11: 327-335
35. Vizi ES, Kisfali M, and Lorincz T (2013). Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects. Brain Res Bull, 93: 32-38
36. Muir KW (2006). Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr Opin Pharmacol, 6: 53-60
37. Ikonomidou C and Turski L (2002). Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol, 1: 383-386
38. Liu XQ, Sheng R, and Qin ZH (2009). The neuroprotective mechanism of brain ischemic preconditioning. Acta Pharmacologica Sinica, 30: 1071-1080
39. Mattson MP and Magnus T (2006). Ageing and neuronal vulnerability. Nat Rev Neurosci, 7: 278-294
40. Chen J and Simon R (1997). Ischemic tolerance in the brain. Neurology, 48: 306-311
41. Pugliese AM, Latini S, Corradetti R, and Pedata F (2003). Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors. Br J Pharmacol, 140: 305-314
42. Nishio S, Yunoki M, Chen ZF, Anzivino MJ, and Lee KS (2000). Ischemic tolerance in the rat neocortex following hypothermic preconditioning. J Neurosurg, 93: 845-851
43. Murry CE, Richard VJ, Reimer KA, and Jennings RB (1990). Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res, 66: 913-931
44. Tauskela JS, Aylsworth A, Hewitt M, Brunette E, and Mealing GA (2012). Preconditioning induces tolerance by suppressing glutamate release in neuron culture ischemia models. J Neurochem, 122: 470-481
45. Garcia JH, Liu KF, and Ho KL (1995). Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke, 26: 636-642
46. Rathmell JC and Thompson CB (1999). The central effectors of cell death in the immune system. Annu Rev Immunol, 17: 781-828
47. Wong CH, Bozinovski S, Hertzog PJ, Hickey MJ, and Crack PJ (2008). Absence of glutathione peroxidase-1 exacerbates cerebral ischemia-reperfusion injury by reducing post-ischemic microvascular perfusion. J Neurochem, 107: 241-252
48. Nakka VP, Gusain A, Mehta SL, and Raghubir R (2008). Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol Neurobiol, 37: 7-38
49. Love S (2003). Apoptosis and brain ischaemia. Prog Neuropsychopharmacol Biol Psychiatry, 27: 267-282
50. Zhang F, Yin W, and Chen J (2004). Apoptosis in cerebral ischemia: executional and regulatory signaling mechanisms. Neurological Research, 26: 835-845
51. Sharp FR, Lu A, Tang Y, and Millhorn DE (2000). Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab, 20: 1011-1032
52. Andersen MB and Sams-Dodd F (1998). Impairment of working memory in the T-maze after transient global cerebral ischemia in the Mongolian gerbil. Behav Brain Res, 91: 15-22
53. Sastry PS and Rao KS (2000). Apoptosis and the nervous system. J Neurochem, 74: 1-20
54. Woodgate A, Walton M, MacGibbon GA, and Dragunow M (1999). Inducible transcription factor expression in a cell culture model of apoptosis. Brain Res Mol Brain Res, 66: 211-216
55. Perez-Pinzon MA (2007). Mechanisms of neuroprotection during ischemic preconditioning: lessons from anoxic tolerance. Comp Biochem Physiol A Mol Integr Physiol, 147: 291-299
56. Chauhan NK, Young AM, Gibson CL, and Davidson C (2013). Inhibition of pre-ischeamic conditioning in the mouse caudate brain slice by NMDA-or adenosine A1 receptor antagonists. Eur J Pharmacol, 698: 322-329
57. Li Q, Lian C, Zhou R, Li T, Xiang X, and Liu B (2013). Pretreatment with xenon protected immature rabbit heart from ischaemia/reperfusion injury by opening of the mitoKATP channel. Heart Lung Circ, 22: 276-283
58. Liu W, Liu Y, Chen H, Liu K, Tao H, and Sun X (2013). Xenon preconditioning: molecular mechanisms and biological effects. Med Gas Res, 3: 3
59. Mio Y, Shim YH, Richards E, Bosnjak ZJ, Pagel PS, and Bienengraeber M (2009). Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats. Anesth Analg, 108: 858-866
60. Dragasis S, Bassiakou E, Iacovidou N, Papadimitriou L, Andreas Steen P, Gulati A, and Xanthos T (2013). The role of opioid receptor agonists in ischemic preconditioning. Eur J Pharmacol, in press
61. Collins MA, Neafsey EJ, Wang K, Achille NJ, Mitchell RM, and Sivaswamy S (2010). Moderate ethanol preconditioning of rat brain cultures engenders neuroprotection against dementia-inducing neuroinflammatory proteins: possible signaling mechanisms. Mol Neurobiol, 41: 420-425
62. Busija DW, Lacza Z, Rajapakse N, Shimizu K, Kis B, Bari F, Domoki F, and Horiguchi T (2004). Targeting mitochondrial ATP-sensitive potassium channels-a novel approach to neuroprotection. Brain Res Brain Res Rev, 46: 282-294
63. Liu D, Lu C, Wan R, Auyeung WW, and Mattson MP (2002). Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J Cereb Blood Flow Metab, 22: 431-443
64. Nagy K, Kis B, Rajapakse NC, Bari F, and Busija DW (2004). Diazoxide preconditioning protects against neuronal cell death by attenuation of oxidative stress upon glutamate stimulation. J Neurosci Res, 76: 697-704
65. Ghatta S, Nimmagadda D, Xu X, and O'Rourke ST (2006). Large-conductance, calcium-activated potassium channels: structural and functional implications. Pharmacol Ther, 110: 103-116
66. Gaspar T, Katakam P, Snipes JA, Kis B, Domoki F, Bari F, and Busija DW (2008). Delayed neuronal preconditioning by NS1619 is independent of calcium activated potassium channels. J Neurochem, 105: 1115-1128
67. Gaspar T, Domoki F, Lenti L, Katakam PV, Snipes JA, Bari F, and Busija DW (2009). Immediate neuronal preconditioning by NS1619. Brain Res, 1285: 196-207
68. Vanhoutte P and Bading H (2003). Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation. Curr Opin Neurobiol, 13: 366-371
69. Chuang DM, Gao XM, and Paul SM (1992). N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells. Mol Pharmacol, 42: 210-216
70. Dickie BG, Holmes C, and Greenfield SA (1996). Neurotoxic and neurotrophic effects of chronic N-methyl-D-aspartate exposure upon mesencephalic dopaminergic neurons in organotypic culture. Neuroscience, 72: 731-741
71. Boeck CR, Kroth EH, Bronzatto MJ, and Vendite D (2005). Adenosine receptors co-operate with NMDA preconditioning to protect cerebellar granule cells against glutamate neurotoxicity. Neuropharmacology, 49: 17-24
72. Pringle AK, Thomas SJ, Signorelli F, and Iannotti F (1999). Ischaemic pre-conditioning in organotypic hippocampal slice cultures is inversely correlated to the induction of the 72 kDa heat shock protein (HSP72). Brain Res, 845: 152-164
73. Valentim LM, Rodnight R, Geyer AB, Horn AP, Tavares A, Cimarosti H, Netto CA, and Salbego CG (2003). Changes in heat shock protein 27 phosphorylation and immunocontent in response to preconditioning to oxygen and glucose deprivation in organotypic hippocampal cultures. Neuroscience, 118: 379-386
74. Jiang X, Tian F, Mearow K, Okagaki P, Lipsky RH, and Marini AM (2005). The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons. J Neurochem, 94: 713-722
75. Ogita K, Okuda H, Yamamoto Y, Nishiyama N, and Yoneda Y (2003). In vivo neuroprotective role of NMDA receptors against kainate-induced excitotoxicity in murine hippocampal pyramidal neurons. J Neurochem, 85: 1336-1346
76. Miao B, Yin XH, Pei DS, Zhang QG, and Zhang GY (2005). Neuroprotective effects of preconditioning ischemia on ischemic brain injury through down-regulating activation of JNK1/2 via N-methyl-D-aspartate receptor-mediated Akt1 activation. J Biol Chem, 280: 21693-21699
77. Boeck CR, Ganzella M, Lottermann A, and Vendite D (2004). NMDA preconditioning protects against seizures and hippocampal neurotoxicity induced by quinolinic acid in mice. Epilepsia, 45: 745-750
78. Piermartiri TC, Vandresen-Filho S, de Araujo Herculano B, Martins WC, Dal'agnolo D, Stroeh E, Carqueja CL, Boeck CR, and Tasca CI (2009). Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake. Neurotox Res, 16: 106-115
79. Ciruela F, Fernandez-Duenas V, Llorente J, Borroto-Escuela D, CuffiML, Carbonell L, Sanchez S, Agnati LF, Fuxe K, and Tasca CI (2012). G protein-coupled receptor oligomerization and brain integration: focus on adenosinergic transmission. Brain Res, 1476: 86-95
80. de Araujo Herculano B, Vandresen-Filho S, Martins WC, Boeck CR, and Tasca CI (2011). NMDA preconditioning protects against quinolinic acid-induced seizures via PKA, PI3K and MAPK/ERK signaling pathways. Behav Brain Res, 219: 92-97
81. do Amaral e Silva Muller G, Vandresen-Filho S, Tavares CP, Menegatti AC, Terenzi H, Tasca CI, and Severino PC (2013). Proteomic analysis of the mice hippocampus after preconditioning induced by N-methyl-D-aspartate (NMDA). J Mol Neurosci, 50: 154-164
82. Marini AM and Paul SM (1992). N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Proc Natl Acad Sci U S A, 89: 6555-6559
83. Danielisova V, Nemethova M, Gottlieb M, and Burda J (2005). Changes of endogenous antioxidant enzymes during ischemic tolerance acquisition. Neurochem Res, 30: 559-565
84. Puisieux F, Deplanque D, Bulckaen H, Maboudou P, Gele P, Lhermitte M, Lebuffe G, and Bordet R (2004). Brain ischemic preconditioning is abolished by antioxidant drugs but does not up-regulate superoxide dismutase and glutathion peroxidase. Brain Res, 1027: 30-37
85. Vandresen-Filho S, de Araujo Herculano B, Franco JL, Boeck CR, Dafre AL, and Tasca CI (2007). Evaluation of glutathione metabolism in NMDA preconditioning against quinolinic acid-induced seizures in mice cerebral cortex and hippocampus. Brain Res, 1184: 38-45
86. Soriano FX, Papadia S, Hofmann F, Hardingham NR, Bading H, and Hardingham GE (2006). Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neurosci, 26: 4509-4518
87. Vandresen-Filho S, Hoeller AA, Herculano BA, Duzzioni M, Duarte FS, Piermartiri TC, Boeck CC, de Lima TC, Marino-Neto J, and Tasca CI (2012). NMDA Preconditioning Attenuates Cortical and Hippocampal Seizures Induced by Intracerebroventricular Quinolinic Acid Infusion. Neurotox Res, 24: 55-62
88. Costa T, Constantino LC, Mendonca BP, Pereira JG, Herculano B, Tasca CI, and Boeck CR (2010). N-methyl-D-aspartate preconditioning improves short-term motor deficits outcome after mild traumatic brain injury in mice. J Neurosci Res, 88: 1329-1337
89. Tsang A, Hausenloy DJ, and Yellon DM (2005). Myocardial postconditioning: reperfusion injury revisited. Am J Physiol Heart Circ Physiol, 289: H2-7
90. Scartabelli T, Gerace E, Landucci E, Moroni F, and Pellegrini-Giampietro DE (2008). Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K-Akt signaling pathway: a novel postconditioning strategy? Neuropharmacology, 55: 509-516
91. Danielisova V, Gottlieb M, Nemethova M, Kravcukova P, Domorakova I, Mechirova E, and Burda J (2009). Bradykinin postconditioning protects pyramidal CA1 neurons against delayed neuronal death in rat hippocampus. Cell Mol Neurobiol, 29: 871-878
92. Nagy D, Kocsis K, Fuzik J, Marosi M, Kis Z, Teichberg VI, Toldi J, and Farkas T (2011). Kainate postconditioning restores LTP in ischemic hippocampal CA1: onset-dependent second pathophysiological stress. Neuropharmacology 61, 1026-1032
93. Zhang W, Miao Y, Zhou S, Jiang J, Luo Q, and Qiu Y (2011). Neuroprotective effects of ischemic postconditioning on global brain ischemia in rats through upregulation of hippocampal glutamine synthetase. J Clin Neurosci, 1: 685-689
94. Zhao H, Sapolsky RM, and Steinberg GK (2006). Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab, 26: 1114-1121
95. Pignataro G, Meller R, Inoue K, Ordonez AN, Ashley MD, Xiong Z, Gala R, and Simon RP (2008). In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning. J Cereb Blood Flow Metab 28, 232-241
96. Burda J, Danielisova V, Nemethova M, Gottlieb M, Matiasova M, Domorakova I, Mechirova E, Ferikova M, Salinas M, and Burda R (2006). Delayed postconditionig initiates additive mechanism necessary for survival of selectively vulnerable neurons after transient ischemia in rat brain. Cell Mol Neurobiol, 26: 1141-1151
97. Ren C, Gao X, Niu G, Yan Z, Chen X, and Zhao H (2008). Delayed postconditioning protects against focal ischemic brain injury in rats. PLoS One, 3: e3851
98. Na HS, Kim YI, Yoon YW, Han HC, Nahm SH, and Hong SK (1996). Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am Heart J, 132: 78-83
99. Mewton N, Thibault H, Roubille F, Lairez O, Rioufol G, Sportouch C, Sanchez I, Bergerot C, Cung TT, Finet G, Angoulvant D, Revel D, Bonnefoy-Cudraz E, Elbaz M, Piot C, Sahraoui I, Croisille P, and Ovize M (2013). Postconditioning attenuates no-reflow in STEMI patients. Basic Res Cardiol 108: 383
100. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, Aupetit JF, Bonnefoy E, Finet G, André-Fouët X, Ovize M. (2005). Postconditioning the human heart. Circulation, 14: 2143-2148
101. Zhang W, Miao Y, Zhou S, Wang B, Luo Q, and Qiu Y (2010). Involvement of Glutamate Transporter-1 in Neuroprotection against Global Brain Ischemia-Reperfusion Injury Induced by Postconditioning in Rats. International Journal of Molecular Sciences, 11: 4407-4416
102. Nemethova M, Danielisova V, Gottlieb M, Kravcukova P, and Burda J (2010). Ischemic postconditioning in the rat hippocampus: mapping of proteins involved in reversal of delayed neuronal death. Arch Ital Biol, 148: 23-32
103. Gidday JM, Shah AR, Maceren RG, Wang Q, Pelligrino DA, Holtzman DM, and Park TS (1999). Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J Cereb Blood Flow Metab, 19: 331-340
104. Peng B, Guo QL, He ZJ, Ye Z, Yuan YJ, Wang N, and Zhou J (2012). Remote ischemic postconditioning protects the brain from global cerebral ischemia/reperfusion injury by up-regulating endothelial nitric oxide synthase through the PI3K/Akt pathway. Brain Res, 1445: 92-102
105. Rosell A, Ortega-Aznar A, Alvarez-Sabin J, Fernandez-Cadenas I, Ribo M, Molina CA, Lo EH, and Montaner J (2006). Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke, 37: 1399-1406
106. Pirici D, Pirici I, Mogoanta L, Margaritescu O, Tudorica V, Margaritescu C, Ion DA, Simionescu C, and Coconu M (2012). Matrix metalloproteinase-9 expression in the nuclear compartment of neurons and glial cells in aging and stroke. Neuropathology 32, 492-504
107. Liu XR, Luo M, Yan F, Zhang CC, Li SJ, Zhao HP, Ji XM, and Luo YM (2012). Ischemic postconditioning diminishes matrix metalloproteinase 9 expression and attenuates loss of the extracellular matrix proteins in rats following middle cerebral artery occlusion and reperfusion. CNS Neurosci Ther, 18: 855-863
108. Sun J, Luan Q, Dong H, Song W, Xie K, Hou L, and Xiong L (2012). Inhibition of mitochondrial permeability transition pore opening contributes to the neuroprotective effects of ischemic postconditioning in rats. Brain Res, 1436: 101-110
109. Hausenloy DJ, Duchen MR, and Yellon DM (2003). Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovascular Research, 60: 617-625
110. Andrukhiv A, Costa AD, West IC, and Garlid KD (2006). Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol, 291: H2067-2074
111. Loukogeorgakis SP, Williams R, Panagiotidou AT, Kolvekar SK, Donald A, Cole TJ, Yellon DM, Deanfield JE, and MacAllister RJ (2007). Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism. Circulation, 116: 1386-1395
112. Sun J, Tong L, Luan Q, Deng J, Li Y, Li Z, Dong H, and Xiong L (2012). Protective effect of delayed remote limb ischemic postconditioning: role of mitochondrial K(ATP) channels in a rat model of focal cerebral ischemic reperfusion injury. J Cereb Blood Flow Metab, 32: 851-859
113. Danial NN and Korsmeyer SJ (2004). Cell death: critical control points. Cell, 116: 205-219
114. Ding ZM, Wu B, Zhang WQ, Lu XJ, Lin YC, Geng YJ, and Miao YF (2012). Neuroprotective Effects of Ischemic Preconditioning and Postconditioning on Global Brain Ischemia in Rats through the Same Effect on Inhibition of Apoptosis. International Journal of Molecular Sciences, 13: 6089-6101
115. Zhang W, Wang B, Zhou S, and Qiu Y (2012). The effect of ischemic post-conditioning on hippocampal cell apoptosis following global brain ischemia in rats. J Clin Neurosci 19, 570-573
116. Gao X, Zhang H, Takahashi T, Hsieh J, Liao J, Steinberg GK, and Zhao H (2008). The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem 105: 943-955
117. Zhan L, Li D, Liang D, Wu B, Zhu P, Wang Y, Sun W, and Xu E (2012). Activation of Akt/FoxO and inactivation of MEK/ERK pathways contribute to induction of neuroprotection against transient global cerebral ischemia by delayed hypoxic postconditioning in adult rats. Neuropharmacology 63, 873-882
118. Leconte C, Tixier E, Freret T, Toutain J, Saulnier R, Boulouard M, Roussel S, Schumann-Bard P, and Bernaudin M (2009). Delayed hypoxic postconditioning protects against cerebral ischemia in the mouse. Stroke, 40: 3349-3355
119. Rybnikova E, Vorobyev M, Pivina S, and Samoilov M (2012). Postconditioning by mild hypoxic exposures reduces rat brain injury caused by severe hypoxia. Neurosci Lett, 513: 100-105
120. Lee JJ, Li L, Jung HH, and Zuo Z (2008). Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology, 108: 1055-1062
121. Adamczyk S, Robin E, Simerabet M, Kipnis E, Tavernier B, Vallet B, Bordet R, and Lebuffe G (2010). Sevoflurane pre-and post-conditioning protect the brain via the mitochondrial K ATP channel. Br J Anaesth, 104: 191-200
122. Wang JK, Yu LN, Zhang FJ, Yang MJ, Yu J, Yan M, and Chen G (2010). Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res, 1357: 142-151
123. Li L and Zuo Z (2011). Isoflurane postconditioning induces neuroprotection via Akt activation and attenuation of increased mitochondrial membrane permeability. Neuroscience, 199: 44-50
124. Fang Li Q, Xu H, Sun Y, Hu R, and Jiang H (2012). Induction of inducible nitric oxide synthase by isoflurane post-conditioning via hypoxia inducible factor-1alpha during tolerance against ischemic neuronal injury. Brain Res, 1451: 1-9
125. Ye Z, Guo Q, Xia P, Wang N, Wang E, and Yuan Y (2012). Sevoflurane postconditioning involves an up-regulation of HIF-1alpha and HO-1 expression via PI3K/Akt pathway in a rat model of focal cerebral ischemia. Brain Res, 1463: 63-74
126. McMurtrey RJ and Zuo Z (2010). Isoflurane preconditioning and postconditioning in rat hippocampal neurons. Brain Res, 1358: 184-190
127. Leonard AS, Bayer KU, Merrill MA, Lim IA, Shea MA, Schulman H, and Hell JW (2002). Regulation of calcium/calmodulin-dependent protein kinase II docking to N-methyl-D-aspartate receptors by calcium/calmodulin and alpha-actinin. J Biol Chem, 277: 48441-48448
128. Wang H, Luo M, Li C, and Wang G (2011). Propofol post-conditioning induced long-term neuroprotection and reduced internalization of AMPAR GluR2 subunit in a rat model of focal cerebral ischemia/reperfusion. J Neurochem, 119: 210-219
129. Liu J, Xu Q, Wang H, Wang R, and Hou XY (2013). Neuroprotection of ischemic postconditioning by downregulating the postsynaptic signaling mediated by kainate receptors. Stroke, 44: 2031-2035